TYRAMINE PRESSOR SENSITIVITY CHANGES DURING DEPRENYL TREATMENT

被引:81
作者
SUNDERLAND, T
MUELLER, EA
COHEN, RM
JIMERSON, DC
PICKAR, D
MURPHY, DL
机构
[1] NIMH,CLIN SCI LAB,BETHESDA,MD 20205
[2] NIMH,CLIN NEUROSCI BRANCH,BETHESDA,MD 20205
关键词
D O I
10.1007/BF00427904
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:432 / 437
页数:6
相关论文
共 43 条
[1]  
ASATOOR AM, 1963, LANCET, V2, P733
[2]   MONOAMINE-OXIDASE INHIBITION BY TRANYLCYPROMINE - ASSESSMENT IN HUMAN VOLUNTEERS [J].
BIECK, PR ;
ANTONIN, KH .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (04) :301-308
[3]   (-)DEPRENYL IN THE TREATMENT OF PARKINSONS-DISEASE [J].
BIRKMAYER, W ;
RIEDERER, P ;
YOUDIM, MBH .
CLINICAL NEUROPHARMACOLOGY, 1982, 5 (02) :195-230
[4]  
BLACKWELL B, 1963, LANCET, V2, P849
[5]  
BYCK R, 1975, PHARMACOL BASIS, P152
[6]   CARDIOVASCULAR CHANGES IN RESPONSE TO SELECTIVE MONOAMINE-OXIDASE INHIBITION IN THE RAT [J].
COHEN, RM ;
CAMPBELL, IC ;
YAMAGUCHI, I ;
PICKAR, D ;
KOPIN, IJ ;
MURPHY, DL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1982, 80 (01) :155-160
[7]   ORAL ABSORPTION AND CONCENTRATION-EFFECT RELATIONSHIP OF TYRAMINE WITH AND WITHOUT CIMOXATONE, A TYPE-A SPECIFIC INHIBITOR OF MONOAMINE-OXIDASE [J].
DOLLERY, CT ;
BROWN, MJ ;
DAVIES, DS ;
LEWIS, PJ ;
STROLINBENEDETTI, M .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (05) :651-662
[8]   DEPRENYL IN PARKINSON DISEASE [J].
EISLER, T ;
TERAVAINEN, H ;
NELSON, R ;
KREBS, H ;
WEISE, V ;
LAKE, CR ;
EBERT, MH ;
WHETZEL, N ;
MURPHY, DL ;
KOPIN, IJ ;
CALNE, DB .
NEUROLOGY, 1981, 31 (01) :19-23
[9]   DEPRENYL ADMINISTRATION IN MAN - SELECTIVE MONO-AMINE OXIDASE-B INHIBITOR WITHOUT CHEESE EFFECT [J].
ELSWORTH, JD ;
GLOVER, V ;
REYNOLDS, GP ;
SANDLER, M ;
LEES, AJ ;
PHUAPRADIT, P ;
SHAW, KM ;
STERN, GM ;
KUMAR, P .
PSYCHOPHARMACOLOGY, 1978, 57 (01) :33-38
[10]   SELECTIVE MONOAMINE-OXIDASE INHIBITOR DRUGS AS AIDS IN EVALUATING ROLE OF TYPE-A AND B ENZYMES [J].
FUENTES, JA ;
NEFF, NH .
NEUROPHARMACOLOGY, 1975, 14 (11) :819-825